About REVATIO® (sildenafil) | Safety Info

Why Revatio

For 12 years, brand-name REVATIO has helped treat pulmonary arterial hypertension (PAH) in adults. If you have PAH, ask your doctor about moving forward with brand-name REVATIO–only from Pfizer.

REVATIO is clinically proven

  • In a clinical study of 267 PAH patients, REVATIO taken with epoprostenol:

  • Increased the distance people walked in a 6-minute defined time

  • Decreased pressure in the pulmonary artery

  • Helped lessen symptoms of PAH§

  • Helped slow down worsening changes in physical condition||

All patients continued intravenous epoprostenol therapy.

Patients on REVATIO achieved a statistically important reduction in mPAP vs placebo.

§Measured by improvements in WHO functional class (classifies patients based on limitations of physical activity and symptoms).

||REVATIO patients had a significant delay to clinical worsening and were less likely to experience clinical worsening (death, lung transplantation, initiation of bosentan, or clinical deterioration) vs placebo.

Revatio is the brand you recognize

  • The REVATIO pill has a distinctive shape and marking to let you know you're getting the brand-name medication—pill to pill, month to month

  • Brand-name REVATIO is from a company you know—only from Pfizer

  • You have the assurance that Pfizer stands behind its manufacturing standards

Revatio Offers Savings To Patients

If eligible, patients may pay as little as $0 each month for brand-name REVATIO—and could save up to $12,000 a year.*


You Are Leaving Revatio.com

Links to another site are provided as a convenience to the viewer.

Pfizer accepts no responsibility for the content of linked sites.